NCAM1 and Parkinson disease: Among them, C32 (CD56+, CD16+, CD57−, CD28−) and C27 (CD56+, CD16+, CD57+, CD28−) increased in PD patients compared to those in HCs, and both increased in patients with LOPD compared to those in EHCs (Fig. 3a, b, f, g).